Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation

Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01299441

Enrollment

Registered

2011-02-18

Start date

2011-02-28

Completion date

2016-10-31

Last updated

2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Brief summary

The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

Interventions

DEVICEECOM ETT

Intubation with ECOM endotracheal tube (ETT)

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing liver transplantation surgery

Exclusion criteria

* Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.

Design outcomes

Primary

Measure	Time frame	Description
endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive	Less than 24 hours	Pulmonary artery catheters are a standard of care for intraoperative hemodynamic assessment during liver transplantation. We propose to compare hemodynamic parameters obtained from PA catheters and ECOM. Use the endotracheal cardiac output monitor (ECOM) to evaluate multiple hemodynamic parameters (invasive blood pressure from the indwelling arterial catheter, noninvasive cardiac output via ECOM), and compare these to the parameters obtained from PA catheter.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026